Brought to you by:
UCLA-SVS review course is this month
Time is running out to plan attendance at the annual course, A Comprehensive Review and Update of What’s New in Vascular and Endovascular Surgery, to be held from Aug. 23–26 at the Beverly Hilton, in Beverly Hills, California. The course…
Corner Stitch: Supplementing our formal learning as vascular trainees
As a vascular surgery trainee, there are multiple aspects of vascular surgery that I’ve had the opportunity to learn about. And to be honest, I’m still learning. To that end, the SVS has put a great deal of effort in…
Breaking ground: A trial to improve the care of uncomplicated type B aortic dissection
Because high-quality evidence from large, prospective multicenter trials on the best treatment of uncomplicated type B aortic dissection (uTBAD) is scarce, SVS members Firas F. Mussa, MD, a professor of vascular surgery at UT-Houston in Houston, Texas, and Panos Kougias,…
VQI Fellows in Training program marks one year
The Vascular Quality Initiative (VQI) Fellows in Training (FIT) program is a success, said leaders as they provided a one-year review. FIT introduces residents and fellows in vascular surgery and medicine to the SVS Patient Safety Organization (PSO). Fellows worked…
SVS members get ready for second annual vascular health awareness event
September’s Vascular Health Step Challenge is fast-approaching, and SVS members are preparing to step up to meet it. The challenge benefits the SVS Foundation, which asks people to walk 60 miles—representing the 60,000 miles of blood vessels in the human…
SVS responds to CMS proposed coverage expansion for carotid stenting
The Society for Vascular Surgery (SVS) and its affiliated Patient Safety Organization (PSO)/Vascular Quality Initiative (VQI) have submitted a formal response to the Centers for Medicare & Medicaid Services (CMS) regarding its proposed national coverage determination on percutaneous transluminal angioplasty…
WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study completes enrolment
Merit Medical has announced that it has completed enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY cell-impermeable endoprosthesis (CIE) to percutaneous transluminal angioplasty (PTA)…
SCVS president becomes chair of American Board of Surgery
The American Board of Surgery (ABS) has named Society for Clinical Vascular Surgery (SCVS) President M. Ashraf Mansour, MBBS, as its 2023–24 chair. He was nominated to the ABS by the Association of Program Directors in Vascular Surgery (APDVS) in…
Light-activated drug-coated balloon granted FDA approval for clinical study
Alucent Biomedical has announced that the Food and Drug Administration (FDA) granted an investigational device exemption (IDE) for a U.S. clinical study of AlucentNVS, a light-activated, drug-coated balloon catheter technology. AlucentNVS combines an intravascular device with a photochemical process to…
‘Vascular surgery should be a key member of pulmonary embolism response teams’
“PERT care is the coalition of the willing,” quipped Dennis Gable, MD, a vascular surgeon at Texas Vascular Associates in Plano, Texas. He was referring to team-based care for pulmonary embolism (PE) patients and how, unlike acute stroke intervention and…